Masimo Corporation (0JZ2.L)
USD 172.78
(-1.63%)
USD 172.78
(-1.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.67 Billion USD | -10.42% |
| 2022 | 1.87 Billion USD | 455.79% |
| 2021 | 336.76 Million USD | 10.45% |
| 2020 | 304.91 Million USD | 33.58% |
| 2019 | 228.25 Million USD | 22.88% |
| 2018 | 185.75 Million USD | -8.64% |
| 2017 | 203.32 Million USD | -21.89% |
| 2016 | 260.28 Million USD | -20.16% |
| 2015 | 326.02 Million USD | 26.73% |
| 2014 | 257.26 Million USD | 129.17% |
| 2013 | 112.26 Million USD | 11.95% |
| 2012 | 100.27 Million USD | 16.01% |
| 2011 | 86.43 Million USD | 7.78% |
| 2010 | 80.19 Million USD | 20.31% |
| 2009 | 66.65 Million USD | -9.87% |
| 2008 | 73.95 Million USD | -13.44% |
| 2007 | 85.44 Million USD | -16.32% |
| 2006 | 102.11 Million USD | -49.37% |
| 2005 | 201.67 Million USD | 0.0% |
| 2003 | 155.79 Million USD | 17.32% |
| 2002 | 132.79 Million USD | 0.0% |
| 1999 | 5.1 Million USD | 59.38% |
| 1998 | 3.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.52 Billion USD | -4.23% |
| 2024 Q1 | 1.59 Billion USD | -5.02% |
| 2024 Q3 | 1.62 Billion USD | 6.52% |
| 2023 Q1 | 1.78 Billion USD | -4.62% |
| 2023 Q2 | 1.7 Billion USD | -4.61% |
| 2023 Q4 | 1.67 Billion USD | -2.53% |
| 2023 Q3 | 1.72 Billion USD | 1.02% |
| 2023 FY | 1.67 Billion USD | -10.42% |
| 2022 Q4 | 1.87 Billion USD | 3.76% |
| 2022 Q3 | 1.8 Billion USD | 2.58% |
| 2022 Q1 | 326.65 Million USD | -3.0% |
| 2022 Q2 | 1.75 Billion USD | 438.3% |
| 2022 FY | 1.87 Billion USD | 455.79% |
| 2021 Q2 | 290.45 Million USD | 7.7% |
| 2021 Q3 | 298.63 Million USD | 2.82% |
| 2021 Q1 | 269.68 Million USD | -11.55% |
| 2021 Q4 | 336.76 Million USD | 12.77% |
| 2021 FY | 336.76 Million USD | 10.45% |
| 2020 FY | 304.91 Million USD | 33.58% |
| 2020 Q2 | 291.08 Million USD | 31.56% |
| 2020 Q3 | 298.33 Million USD | 2.49% |
| 2020 Q4 | 304.91 Million USD | 2.2% |
| 2020 Q1 | 221.26 Million USD | -3.06% |
| 2019 Q4 | 228.25 Million USD | 10.88% |
| 2019 FY | 228.25 Million USD | 22.88% |
| 2019 Q3 | 205.85 Million USD | 8.36% |
| 2019 Q2 | 189.97 Million USD | 8.99% |
| 2019 Q1 | 174.3 Million USD | -6.17% |
| 2018 FY | 185.75 Million USD | -8.64% |
| 2018 Q4 | 185.75 Million USD | 1.25% |
| 2018 Q1 | 183.04 Million USD | -9.97% |
| 2018 Q2 | 182.12 Million USD | -0.5% |
| 2018 Q3 | 183.46 Million USD | 0.73% |
| 2017 Q2 | 186.26 Million USD | -23.57% |
| 2017 Q1 | 243.71 Million USD | -6.37% |
| 2017 FY | 203.32 Million USD | -21.89% |
| 2017 Q4 | 203.32 Million USD | 7.7% |
| 2017 Q3 | 188.78 Million USD | 1.36% |
| 2016 Q3 | 306.26 Million USD | -0.41% |
| 2016 Q2 | 307.53 Million USD | -12.95% |
| 2016 FY | 260.28 Million USD | -20.16% |
| 2016 Q1 | 353.27 Million USD | 8.36% |
| 2016 Q4 | 260.28 Million USD | -15.01% |
| 2015 Q4 | 326.02 Million USD | 5.32% |
| 2015 Q1 | 250.52 Million USD | -2.62% |
| 2015 FY | 326.02 Million USD | 26.73% |
| 2015 Q2 | 299.55 Million USD | 19.57% |
| 2015 Q3 | 309.55 Million USD | 3.34% |
| 2014 Q3 | 248.36 Million USD | 38.47% |
| 2014 Q1 | 105.21 Million USD | -6.28% |
| 2014 FY | 257.26 Million USD | 129.17% |
| 2014 Q2 | 179.36 Million USD | 70.49% |
| 2014 Q4 | 257.26 Million USD | 3.58% |
| 2013 FY | 112.26 Million USD | 11.95% |
| 2013 Q3 | 113.87 Million USD | 9.76% |
| 2013 Q2 | 103.74 Million USD | -3.28% |
| 2013 Q4 | 112.26 Million USD | -1.41% |
| 2013 Q1 | 107.26 Million USD | 6.96% |
| 2012 Q1 | 102.61 Million USD | 18.71% |
| 2012 Q2 | 85.84 Million USD | -16.34% |
| 2012 Q3 | 95.34 Million USD | 11.06% |
| 2012 Q4 | 100.27 Million USD | 5.17% |
| 2012 FY | 100.27 Million USD | 16.01% |
| 2011 FY | 86.43 Million USD | 7.78% |
| 2011 Q4 | 86.43 Million USD | 12.65% |
| 2011 Q3 | 76.73 Million USD | 5.63% |
| 2011 Q2 | 72.64 Million USD | -0.91% |
| 2011 Q1 | 73.31 Million USD | -8.58% |
| 2010 Q1 | 82.75 Million USD | 24.15% |
| 2010 FY | 80.19 Million USD | 20.31% |
| 2010 Q2 | 73.79 Million USD | -10.83% |
| 2010 Q3 | 79.48 Million USD | 7.71% |
| 2010 Q4 | 80.19 Million USD | 0.89% |
| 2009 Q4 | 66.65 Million USD | 2.06% |
| 2009 FY | 66.65 Million USD | -9.87% |
| 2009 Q3 | 65.3 Million USD | 5.35% |
| 2009 Q1 | 68.8 Million USD | -6.97% |
| 2009 Q2 | 61.99 Million USD | -9.9% |
| 2008 Q4 | 73.95 Million USD | 28.79% |
| 2008 Q3 | 57.42 Million USD | -7.74% |
| 2008 Q2 | 62.23 Million USD | 4.7% |
| 2008 Q1 | 59.44 Million USD | -30.43% |
| 2008 FY | 73.95 Million USD | -13.44% |
| 2007 Q1 | 85.99 Million USD | -15.78% |
| 2007 FY | 85.44 Million USD | -16.32% |
| 2007 Q2 | 96.82 Million USD | 12.6% |
| 2007 Q3 | 88.03 Million USD | -9.08% |
| 2007 Q4 | 85.44 Million USD | -2.95% |
| 2006 FY | 102.11 Million USD | -49.37% |
| 2006 Q4 | 102.11 Million USD | 0.0% |
| 2005 Q4 | 201.67 Million USD | 0.0% |
| 2005 FY | 201.67 Million USD | 0.0% |
| 2003 FY | 155.79 Million USD | 17.32% |
| 2002 FY | 132.79 Million USD | 0.0% |
| 1999 FY | 5.1 Million USD | 59.38% |
| 1998 FY | 3.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -1301.501% |
| Accuray Incorporated | 423.54 Million USD | -295.875% |
| Align Technology, Inc. | 2.45 Billion USD | 31.658% |
| Elevance Health Inc. | 69.52 Billion USD | 97.588% |
| AxoGen, Inc. | 101.16 Million USD | -1557.441% |
| Boston Scientific Corporation | 15.6 Billion USD | 89.256% |
| CVS Health Corporation | 173.09 Billion USD | 99.031% |
| Cardinal Health, Inc. | 48.33 Billion USD | 96.531% |
| Centene Corporation | 58.68 Billion USD | 97.143% |
| DaVita Inc. | 14.87 Billion USD | 88.729% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 96.96% |
| Hologic, Inc. | 4.02 Billion USD | 58.353% |
| Humana Inc. | 30.74 Billion USD | 94.547% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 5.559% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 81.021% |
| McKesson Corporation | 69.04 Billion USD | 97.571% |
| Patterson Companies, Inc. | 1.89 Billion USD | 11.52% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 77.95% |
| ResMed Inc. | 2 Billion USD | 16.514% |
| Henry Schein, Inc. | 5.42 Billion USD | 69.065% |
| Teladoc Health, Inc. | 2.06 Billion USD | 18.855% |
| Universal Health Services, Inc. | 8.15 Billion USD | 79.439% |
| Veeva Systems Inc. | 1.26 Billion USD | -32.431% |
| Baxter International Inc. | 19.8 Billion USD | 91.535% |
| Becton, Dickinson and Company | 26.98 Billion USD | 93.786% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 17.978% |
| Danaher Corporation | 30.99 Billion USD | 94.591% |
| Stryker Corporation | 21.31 Billion USD | 92.135% |
| Medtronic plc | 39.56 Billion USD | 95.762% |